Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel Diseases
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Infliximab
Related studies linked through entity extraction aliases.
Infliximab in the Treatment of Patients With Severe COVID-19 Disease
- Status
- COMPLETED
- Phase
- PHASE2
MIS-C Comparative Effectiveness Study
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Cohort Study Comparing IFX to CS for Moderate to Severe UC
- Status
- UNKNOWN
- Phase
- N/A
Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
The Study of Infliximab (CMAB008 and Remicade) in Healthy Subjects to Compare the PK and Safety
- Status
- COMPLETED
- Phase
- PHASE1
N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's Disease
- Status
- UNKNOWN
- Phase
- NA
Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome
- Status
- COMPLETED
- Phase
- N/A
CHronic Nonbacterial Osteomyelitis International Registry
- Status
- RECRUITING
- Phase
- N/A
Biomarkers to Predict and Monitor Response to Infliximab
- Status
- UNKNOWN
- Phase
- N/A
De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE4
Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- Status
- UNKNOWN
- Phase
- PHASE3
Immune Modulators for Treating COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease
- Status
- WITHDRAWN
- Phase
- PHASE3
Exclusive Enteral Nutrition vs. Infliximab in Chinese CD Patients
- Status
- WITHDRAWN
- Phase
- PHASE4
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).
- Status
- COMPLETED
- Phase
- PHASE2
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial
- Status
- UNKNOWN
- Phase
- PHASE3